The authors determined the incidence of complications in 133 patients who had undergone staging laparotomy with splenectomy before treatment for Hodgkin's disease (stages I-IV).
tion of laparotomy is the development of small bowel obstruction, usually secondary to adhesions and often necessitating repeat laparotomy. Other surgical complications include postoperative infections and wound dehiscence. Death as a result of surgical complications is rare (0.4%). 5, 6 Laparotomy findings can be predicted from clinical findings and diagnostic imaging in only small subsets of patients. 7 In addition, the pathologic or laparotomy stage differs from the clinical stage in 25% to 45% of patients undergoing laparotomy. Finally, the therapeutic cost of uncertainty regarding the presence and extent ofabdominal disease may be substantial (e.g., the addition of two to six cycles of chemotherapy to the treatment regimen). Before laparotomy is eliminated from the staging of patients with Hodgkin's disease because of concern over potential infectious and surgical complications, the risks in the current era, in which many infectious complications can be avoided by appropriate prophylaxis, must be reevaluated.
This study examined the incidence of OPSI, other serious infections, and surgical complications after laparotomy in 133 patients treated for Hodgkin's disease at the University of Florida.
METHODS AND MATERIALS
All patients with Hodgkin's disease who underwent staging laparotomy with splenectomy and were treated with curative intent at the University of Florida between October 1964 and July 1989 were studied (analysis date, March 1992) . One hundred forty patients were identified, but seven who were lost to follow-up after 6 to 9 years of observation with no record of complications were excluded from analysis. The remaining 133 patients were included in the study.
The current medical records of all patients were reviewed. In addition, 93 patients were interviewed personally, and close relatives of an additional 3 patients were interviewed. In eight patients who had no personal interview, medical records were available with more than 11 years of follow-up after laparotomy. In addition, the medical records of the 29 patients who died were reviewed. The median follow-up was 15.7 years (range = 2.5-28 years).
The patients' median age was 24 years. The male-tofemale ratio was 2:1, with a preponderance of male patients in the younger age ranges. The majority ofpatients (95%) had stage I, II, or III disease, with approximately equal numbers of patients in each stage (29%, 34%, and 32%, respectively). Only seven patients (5%) had stage IV disease. Ninety-one patients (68%) were treated with radiotherapy alone and 42 patients (32%) were treated with chemotherapy and radiation therapy. As expected, patients with less advanced disease were more likely to receive radiotherapy alone, and those with advanced disease were more likely to receive combined modality treatment (Fig. 1) .
During interviews, patients were questioned concerning the occurrence of infections and surgical complications, such as small bowel obstruction, postoperative infections, and wound dehiscence. In addition, each patient's vaccination history, with regard to pneumococcal, Haemophilus influenzae, and Neisseria meningitidis vaccinations, was ascertained. Medical records from the University of Florida and outside institutions were used to confirm data obtained from the patient interviews. In addition, hospital discharge summaries, laboratory data, and progress notes were obtained to document laparotomy complications.
For the purpose of this study, OPSI was defined as a microbiologically documented meningitis or septicemia occurring acutely in previously nonfebrile and noninfected persons, in the absence of severe myelosuppression.8 "Other serious infections" were defined as pneumonia or other infections requiring hospitalization that did not fit the criteria for OPSI.
RESULTS OPSI
Ten episodes of OPSI in 9 patients were observed, representing an incidence of 6.8%. Six of the ten episodes involved organisms associated classically with postsplenectomy infections (Table 1) The time interval between splenectomy and the first episode of OPSI ranged from 0.1 to 17.3 years, with a median of4.6 years. Five of nine patients who developed OPSI did so within the first 5-year interval immediately after splenectomy (Fig. 2) . In addition, the number of patients developing OPSI decreased in the second, third, and fourth 5-year intervals after splenectomy, suggesting that the first 5 years after splenectomy may be the period of highest risk for developing OPSI.
Other Serious Infections
Other serious infections observed in this study include 26 episodes of clinical pneumonia in 23 patients (Table  2 ). The organisms responsible for pneumonia are not least three cycles of MOPP (mechlorethamine, vincristine, procarbazine, prednisone) chemotherapy at some point in treatment. These patients developed leukemia 1.5 to 7.5 years (mean 4.5 years) after completing chemotherapy. Three patients died of bone marrow failure and two died from solid malignancies. In one patient, the cause of death could not be determined precisely; however, he had advanced Hodgkin's disease (stage IIB) and had undergone chemotherapy and radiation therapy for multiple recurrences.
DISCUSSION
Overwhelming postsplenectomy infection was first described in children. Although it has been reported more frequently in children than in adults, it can occur at any age. '9 In a review of 4846 pediatric and adult patients who had splenectomy for trauma, malignancy, and other causes, the crude frequency of OPSI was estimated to be as high as 3.9%.6 However, in children who had splenectomy for Hodgkin's disease, the crude frequency ofOPSI has been estimated as high as 10%.10-12 The 6.8% incidence ofOPSI observed in this patient population is consistent with other reports ofpatients undergoing laparotomy before the routine use of prophylactic, presplenectomy vaccination (Table 4 ). The infecting organism in OPSI is usually S. pneumoniae, but N. meningitis, H. influenzae, B-hemolytic streptococci, Escherichia coli, and other organisms also have been found." 4" 3 The pathophysiology of OPSI is not understood completely; however, removal of the spleen impairs humoral responsiveness and can modify production of specific antibodies to microbial antigens. In addition, in Hodgkin's disease, both cell-mediated and humoral immune mechanisms are impaired. 4 splenectomy. Although prophylactic antibiotics also may protect against OPSI, their use may lead to the development of resistant organisms. In addition, their efficacy depends on compliance by patients. Only 28 patients in this series used prophylactic antibiotics for the 2 years after splenectomy. Among this group, there were four episodes of OPSI and six other serious infections. Some of these patients, however, may have been treated with antibiotics after developing infections. Donaldson and Kaplan22 agree with the results of this study that patients with advanced or recurrent disease and those treated with combined modality therapy may be at higher risk for developing OPSI. These high-risk patients might benefit from aggressive use of prophylactic antibiotics, in addition to routine vaccinations, both before and after splenectomy, although the role of postsplenectomy revaccination is undetermined."8
It is not clear why the first 5 years after splenectomy is a high-risk period for the development of OPSI. Although OPSI sometimes occurs more than 5 years after splenectomy in patients with no other apparent risk factors, occurrence is more likely shortly after the first treatment or during treatment relapse.23 '24 Other serious infections were relatively common, but resulted in no mortality. Because of the immunocompromised state of this patient population, it is difficult to derive any meaningful conclusions about the relationship between other serious infections and splenectomy.
Surgical complication did not cause any deaths. Repeat laparotomy for small bowel obstruction was required in 6.8% of patients. This rate is consistent with previous reports of a 1% to 10% incidence of small bowel obstruction. I think that the staging laparotomies have been very useful, and I think they have been worthwhile and that the complication rate is not that bad. I do agree that with the vaccines we have and the ways of caring for respiratory problems should be emphasized. And I also emphasize that the vaccine has to be given at least 2 weeks preoperative or it does very little good. I went down to the x-ray therapy department at Anderson, and also the hematology department to see how things were going, since I have not done laparotomies lately. And I found out that starting in 1988, they no longer were doing laparotomies. They are staging the patients with lymphangiography and CT scan ofthe upper abdomen. As you know, the lymphangiograms will not show you any disease above L-2, and that's where the laparotomies were so important. They are now treating all patients with radiotherapy and chemotherapy to the mediastinum at the upper abdomen unless on lymphangiogram they find nodes below L-2, and then they will radiate them. I think it will be very interesting when they get a good series to compare with the laparotomies and see what the outcome is and what the complication rate is. Ofcourse, in this way they do not do splenectomies, and maybe that will make a difference. That will have to be decided at a later date. I prophylactic vaccination is used before the splenectomy, this greatly decreases the chances of post-operative infection. In their manuscript, they go into more detail, and I want to emphasize a few of those points which they could not cover in the short presentation. First of all, I want to re-emphasize that of the ten patients who developed overwhelming post-splenectomy infection, only one patient died. That has not been, of course, true of many ofthe patients who develop overwhelming post-splenectomy infection, and I think this is a tribute to the very fine care these patients have received in Gainesville. But not all patients undergoing splenectomy will have that advantage in a major medical center where there is such fine surveillance of their patients. And so there is the continuing concern and risk to those patients. I'd like also to emphasize that none of the 25 patients who received pneumococcal vaccine and
